- Research article
- Open Access
Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort
BMC Medicine volume 19, Article number: 290 (2021)
Nutritional factors are essential for the functioning of the immune system and could therefore play a role in COVID-19 but evidence is needed. Our objective was to study the associations between diet and the risk of SARS-CoV-2 infection in a large population-based sample.
Our analyses were conducted in the French prospective NutriNet-Santé cohort study (2009–2020). Seroprevalence of anti-SARS-CoV-2 antibodies was assessed by ELISA on dried blood spots. Dietary intakes were derived from repeated 24 h dietary records (at least 6) in the two years preceding the start of the COVID-19 pandemic in France (February 2020). Multi-adjusted logistic regression models were computed.
A total of 7766 adults (70.3% women, mean age: 60.3 years) were included, among which 311 were positive for anti-SARS-CoV-2 antibodies. Dietary intakes of vitamin C (OR for 1 SD=0.86 (0.75–0.98), P=0.02), vitamin B9 (OR=0.84 (0.72–0.98), P=0.02), vitamin K (OR=0.86 (0.74–0.99), P=0.04), fibers (OR=0.84 (0.72–0.98), P=0.02), and fruit and vegetables (OR=0.85 (0.74–0.97), P=0.02) were associated to a decreased probability of SARS-CoV-2 infection while dietary intakes of calcium (OR=1.16 (1.01–1.35), P=0.04) and dairy products (OR=1.19 (1.06–1.33), P=0.002) associated to increased odds. No association was detected with other food groups or nutrients or with the overall diet quality.
Higher dietary intakes of fruit and vegetables and, consistently, of vitamin C, folate, vitamin K and fibers were associated with a lower susceptibility to SARS-CoV-2 infection. Beyond its established role in the prevention of non-communicable diseases, diet could therefore also contribute to prevent some infectious diseases such as COVID-19.
First identified in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has massively spread worldwide, causing coronavirus disease 2019 (COVID-19), a disease ranging from asymptomatic and mild forms to severe forms requiring hospitalization and sometimes leading to death . This paved the way to a vast array of research aiming to describe, understand, and predict various aspects of the COVID-19 pandemic. In particular, the identification of modifiable risk factors associated with the likelihood of being infected may provide some leverage for disease prevention, in parallel to vaccination programs.
Many hypotheses were raised regarding a putative role of nutrition in COVID-19, in the susceptibility to infection, in the severity of the disease and associated outcomes [2, 3]. The foods we eat indeed provide us with macronutrients, vitamins, minerals, and other bioactive compounds that are essential for a proper functioning of the immune system [2, 3]. Inadequate nutritional intakes could therefore impair the immune response and lead to a higher susceptibility to SARS-CoV-2 infection.
To our knowledge, two prospective studies have examined the prospective link between dietary intakes and the risk of SARS-CoV-2 infection: a Spanish study using a self-reported COVID-19 questionnaire without objective serology data, suggesting a potential protective association with a higher adherence to the Mediterranean diet . Another study in the UK, used a simplified 17-item food questionnaire, in individuals who voluntarily sought testing by real-time polymerase chain reaction tests (RT-PCR), and suggested a protective association for higher intakes of coffee and vegetables, and higher odds of infection associated with higher intakes of processed meat . Some studies have explored how intakes (mostly through interventions involving vitamins and minerals such as vitamins A, C, and D or zinc) relate to other respiratory tract infections, including the common cold or pneumonia. These studies displayed discordant results, some suggesting an impact on the incidence of infection and/or the duration of symptoms while others showed no effect [6,7,8,9,10,11,12,13]. Studies in the context of COVID-19 have mostly been ecological , or conducted on patients in already infected patients, focusing on the prognosis of the COVID-19 disease, in a context of tertiary prevention [15,16,17,18,19]. These studies provide crucial insights for disease management but they are not appropriate to investigate the potential influence of dietary habits on the risk of being infected by SARS-CoV-2, in a context of primary prevention. While individuals are continuously exposed to various pathogens (among which respiratory viruses), some are more susceptible than others to be effectively infected. Usual diet has been suggested to impact immunity in multiple ways  but its role on the susceptibility to SARS-CoV-2 infection is still unknown. Such information, once validated, could be useful to establish dietary guidelines aiming to lower the risk of infection by SARS-CoV-2 or other respiratory pathogens.
Our objective was therefore to study the associations between dietary intakes (nutrients, food groups, and overall diet quality) and the risk of SARS-CoV-2 infection, objectively assessed through a standardized protocol measuring the seroprevalence of anti-SARS-CoV-2 antibodies, in a large population-based sample.
NutriNet-Santé is a web-based cohort focusing on the relationships between nutrition and health along with the determinants of nutrition-related behaviors . The recruitment of French adults started in 2009 and is still ongoing. The NutriNet-Santé study is conducted in accordance with the Declaration of Helsinki, and all procedures were approved by the Institutional Review Board of the French Institute for Health and Medical Research (IRB INSERM #0000388FWA00005831) and by the National Commission on Informatics and Liberty (CNIL #908,450 and #909,216). All participants provided informed consent and an electronic signature. The study is registered at ClinicalTrials.gov (#NCT03335644).
NutriNet-Santé participants regularly complete questionnaires through a dedicated and secured online platform. Upon inclusion and then every year, a set of 5 validated questionnaires collect data related to sociodemographic and lifestyle characteristics, health status and medication use, dietary intakes, physical activity (short form of the International Physical Activity Questionnaire [IPAQ]) and anthropometrics.
Dietary intakes are assessed every 6 months, each time through 3 non-consecutive, validated 24-hour dietary records, randomly distributed over 2 weeks, including 2 weekdays and 1 weekend day [22,23,24]. Portion sizes are estimated using validated photographs, standard containers, or directly in g/L. The food content in energy, alcohol, and macro- and micro-nutrients are derived from the NutriNet-Santé food composition table which is continuously updated and currently comprise > 3500 items. Amounts of food consumed from composite dishes are estimated using French recipes validated by food and nutrition professionals. Dietary energy under-reporters are detected via the method proposed by Black . Food consumption and nutrient intakes were calculated as an average per day overall 24-h dietary records available (minimum: 6) from January 1, 2018, to February 1, 2020, i.e., the 2 years preceding the start of the COVID-19 pandemic in France.
A specific COVID-19 research protocol was set up in April 2020 as part of the SAPRIS nationwide multi-cohort project , including several questionnaires repeatedly collecting information about participants’ COVID-19 infection/diagnosis and experience of lockdown (e.g., employment status, presence of children at home, frequency of going out in the past week and related protective behaviors, body weight before the lockdown). All NutriNet-Santé questionnaires are available online (in French): https://info.etude-nutrinet-sante.fr/node/11.
Assessment of SARS-CoV-2 seroprevalence
To estimate the seroprevalence of SARS-CoV-2 infection at the population level, participants who completed the SAPRIS questionnaires were invited to take part in the SAPRIS-SERO project (approved by CPP Sud-Méditerranée III on April 27, 2020, and CNIL #920193, electronic informed consent was obtained from all participants for dried-blood spot testing) . Volunteer participants received self-sampling dried-blood spot kits by mail between May and October 2020. After processing, serological analyses were performed using commercial Enzyme-linked immunosorbent assay (ELISA) tests (Euroimmun®, Lübeck, Germany) to detect anti-SARS-CoV-2 antibodies (immunoglobulin G, IgG) directed against the spike protein S1 domain (ELISA-S). The ELISA-S test was considered positive for values of optical density ratio ≥1.1, indeterminate for values between 0.8 and 1.1, and negative for values < 0.8. The main outcome was a positive ELISA-S test. Participants with ELISA-S results in the indeterminate range were excluded from the analyses.
In all, 7766 participants who provided at least 6 valid 24 h dietary records in the 2 years preceding the start of the COVID-19 pandemic in France (i.e., before February 2020) and with either a positive or a negative ELISA-S test were included in the analyses (Flowchart in Additional File 1: Fig. S1). Baseline characteristics of participants according to their seroprevalence status were described.
Associations between dietary intakes before the COVID-19 pandemic and the probability of SARS-CoV-2 infection (positive vs. negative ELISA-S test) were assessed using multivariable logistic regression models. A large range of nutritional exposures were considered to reflect the diversity of dietary intakes: from intakes of energy, macronutrients, dietary fiber, vitamins, and minerals to intakes of main food groups and indicators of the overall diet quality: the proportion of ultra-processed foods in the diet (% of food weight, assessed using the NOVA classification, as previously described ), the Alternative Healthy Eating Index (AHEI)-2010 score (range: 0 to 100; details in Additional File 1: Methods ) reflecting the adherence to a healthy diet , and the simplified Programme National Nutrition Santé-guidelines score 2 (sPNNS-GS2, range: -17 to 14.25; details in Additional file 1: Methods)  reflecting the adherence to the 2017 French dietary guidelines. Dietary intakes were handled as continuous variables and the odds ratios (OR) and 95% confidence intervals (CI) were computed for an increment of 1 standard deviation (SD). The log-linearity assumption was verified using restricted cubic splines  (no evidence of non-linearity). Models were adjusted for the following characteristics, assessed in April 2020 (i.e., during the first lockdown/wave of the epidemics in France): sex, age, educational level, employment status, smoking status, presence of children aged under 18 years at home, residential area, geographical area, frequency of going out over the past week and prevalent chronic disease (cancer, cardiovascular disease, high blood pressure, diabetes, dyslipidemia). The models also included the body mass index (BMI) and physical activity level prior to the March 2020 lockdown, as well as the month of blood draw, the number of 24 h dietary records and the intakes of energy (without alcohol) and alcohol. Finally, models included a composite index reflecting the adherence to 3 recommended protective behaviors when going out, assessed twice (questionnaires in April and May 2020). The index was calculated as the average sum of points attributed to hand washing when going back home (always-3, almost always-2, sometimes-1, never-0), mask-wearing (always-3, sometimes-1.5, never-0), and physical distancing (> 1 meter from others-3, > 1 meter from almost everybody-1.5, < 1 meter-0) and ranged from 0 to 9.
In secondary analyses, we performed multi-adjusted multinomial logistic regressions to identify dietary factors associated with seropositivity with no prior SARS-CoV-2 symptoms, or with seropositivity in participants having had SARS-CoV-2 symptoms (defined as having had at least one of the 4 following symptoms: unusual fever, cough, dyspnea, or anosmia/ageusia), compared with seronegativity. Sensitivity analyses were carried out by additionally adjusting models for the overall quality of the diet, using the sPNNS-GS2 score. Interactions were tested between each nutritional factor and sex by introducing the product of the corresponding 2 variables in the model. We also tested restricting our study sample to a nested case-control design, with matching for age, sex, and residential area (4 controls per case).
All tests were two-sided and P< 0.05 was considered statistically significant. Analyses were carried out using SAS 9.4 (SAS Institute Inc., USA).
Our analyses included 311 ELISA-S positive and 7455 ELISA-S negative participants (70.3% women, mean (SD) age: 60.3 years (12.9), mean number of dietary records: 10.2 (2.7)). Participants’ characteristics according to their ELISA-S status are shown in Table 1. ELISA-S positive participants were younger, more likely to have a graduate degree and a higher income, to have a professional activity during the lockdown (March–May 2020), to have children aged under 18 years at home, to have a lower level of physical activity pre-lockdown, to be non-smokers and to live in cities, and less likely to have a prevalent chronic disease. They were also more likely to have had symptoms of a SARS-CoV-2 infection, and to have been hospitalized or to have called the paramedics for SARS-CoV-2 infection symptoms. Dietary intakes according to ELISA-S status (unadjusted) are shown in Table 2.
Dietary intakes of vitamin B9 (OR=0.84 (0.72,0.98), P=0.02), vitamin C (OR=0.86 (0.75,0.98), P=0.02), vitamin K (OR=0.86 (0.74,0.99), P=0.04) (and more specifically vitamin K of plant origin (OR=0.87 (0.75,1.00), P=0.05)) and dietary fibers (total: OR=0.84 (0.72,0.98), P=0.02; soluble: OR=0.83 (0.71,0.96), P=0.01; insoluble: OR=0.86 (0.74,1.00), P=0.049), and, consistently, the consumption of fruits and vegetables (OR=0.85 (0.74,0.97), P=0.02), were associated with decreased odds of SARS-CoV-2 infection.
Conversely, higher intakes of calcium (OR=1.16 (1.01,1.35), P=0.04) and dairy products (OR=1.19 (1.06,1.33), P=0.002) were associated with increased odds of SARS-CoV-2 infection. This association was especially observed for milk (OR=1.15 (1.03,1.27), P=0.01), with a similar trend for yogurt (OR=1.12 (1.00,1.25), P=0.06), but not for cheese (OR=0.96 (0.84,1.09), P=0.54) or cottage cheese (OR=1.03 (0.92,1.16), P=0.60).
The food groups that contributed the most to the intakes of these nutrients were fruits and vegetables and starchy foods for fibers and vitamin B9, fruits and vegetables and sugary drinks for vitamin C, fruits and vegetables, starchy foods, and dairy products for vitamin K, and dairy products for calcium (Additional file 1: Fig. S2).
No association was observed neither with the other nutrients or food groups nor with the overall dietary scores AHEI-2010 (OR=0.96 (0.85,1.09), P=0.52), sPNNS-GS2 (OR=0.95 (0.82,1.10), P=0.45), or with the proportion of ultra-processed food in the diet (OR=0.96 (0.85,1.08), P=0.52).
Sensitivity analyses with additional adjustment for the overall dietary score sPNNS-GS2 provided similar results (Additional file 1: Table S1).
Only two interactions were detected with sex. While soluble fiber intake exhibited the same trend but only in women (P-interaction=0.02; women: OR=0.70 (0.58,0.85), P=0.0003; men: OR=1.12 (0.87,1.44), P=0.37), a significant association with the risk of SARS-CoV-2 infection was detected in women for the intake of sweet products (P-interaction=0.01; women: OR=1.17 (1.02,1.35), P=0.03; men: OR=0.83 (0.64,1.07), P=0.14).
In secondary analyses, we explored the associations of nutrient intakes and food groups with the odds of having a symptomatic or asymptomatic SARS-CoV-2 infection (Figs. 3, 4, 5, and 6). Intakes of fruit and vegetables as well as vitamins C, K (from plant-based products), and B9 were inversely associated with the odds of a symptomatic SARS-CoV-2 infection. As regards asymptomatic infections, inverse associations were observed for DPA-omega 3 fatty acids and added fats of plant origin, and direct associations were observed for dairy products.
Sensitivity analyses on the nested case-control sample provided similar results (Additional file 1: Figs. S3-S4): higher intakes of fiber, vitamin B9, vitamin C, fruits, and vegetables were associated with lower odds of being seropositive for SARS-CoV-2, while direct associations were observed for dairy products, consistently with the main models. Few differences were observed: vitamin E (OR=0.84 (0.71,0.99), P=0.04) and added fat of plant origin (OR=0.82 (0.70,0.95), P=0.01) were inversely associated with the risk of infection, and direct associations were observed with added fats of animal origin (OR=1.16 (1.01,1.32), P=0.03). On the other hand, associations with vitamin K and calcium were slightly attenuated and became non-significant (P=0.07 and 0.09, respectively).
Our results showed that a diet rich in fruit and vegetables, consistent with higher intakes of vitamin C, vitamin B9, vitamin K, and dietary fiber was associated with a lower probability of SARS-CoV-2 infection, as reflected by seroprevalence data. We also observed that higher intakes of dairy products and calcium were associated with higher odds of SARS-CoV-2 infection. More specifically, higher intakes of vitamins C, K (from plant-based foods), and B9, as well as fruits and vegetables were associated with a lower probability of a symptomatic SARS-CoV-2 infection.
To the best of our knowledge, our study was the first prospective study to use objective serology data, coupled with detailed dietary assessment, to examine the associations between usual diet and the odds of having been infected by SARS-CoV-2. A prospective Spanish study in the SUN cohort observed an association between a better adherence to the Mediterranean diet and a lower risk of SARS-CoV-2 infection . Nevertheless, the outcome assessment in this study was based on self-reported questionnaires collecting SARS-CoV-2 diagnostic tests, and not seroprevalence. On the other hand, a study in the UK-Biobank reported a protective association for higher intakes of coffee and vegetables and higher odds of infection associated with higher intakes of processed meat . However, this study was conducted only among participants who sought COVID-19 testing, and based on a non-detailed dietary assessment, using a simplified 17-item questionnaire.
Vitamin C is a well-known actor of the immune system and could help prevent SARS-CoV-2 infection notably through an enhanced innate immune response with the maintenance of the epithelial barrier defending against pathogens and the promotion of phagocytosis (regulation of neutrophil function, notably increased chemotactic response) [6, 11, 34]. Although rare in developed countries, severe vitamin C deficiency (scurvy) has been observed to predispose individuals to infections, especially of the respiratory tract, like pneumonia . Yet, randomized trials have mostly failed to demonstrate a beneficial effect of vitamin C regarding the common cold, upper respiratory tract infections (URTI), or pneumonia, showing only a weak inconsistent effect on the incidence of infection, but a clearer effect on the duration of symptoms [6,7,8,9,10, 34]. However, these trials usually did not consider dietary intakes of vitamin C, which may have limited the observation of effects if baseline nutritional status was already adequate . Moreover, a prospective cohort study among Swedish adults observed a decreased risk of URTI associated with higher dietary intakes of vitamin C in women . Finally, some studies were performed in the context of COVID-19 but focusing on hospitalized patients, observing low vitamin C status in critically ill patients , and suggesting improved outcomes with high-dose vitamin C treatment . Largely consistent with the current evidence , our results suggest that higher vitamin C intakes as part of the regular diet may decrease the risk of SARS-CoV-2 infection, probably through an enhanced early immune response.
Vitamin B9 (folate) has also been suggested as a potential helper in preventing SARS-CoV-2 infection, through a role in innate immunity and in particular for natural killer cell cytotoxicity, which may reduce the risk of infection, as evidenced in an intervention study in older adults . Evidence more specifically related to SARS-CoV-2 from computer simulation studies suggested that vitamin B9 could prevent the virus from entering the cells through an inhibition of furin, a protease involved in the activation of the spike protein, and from replicating through an inactivation of the protease 3CLpro . Thus, our results are consistent with those mostly mechanistic data; strong direct evidence of the potential of vitamin B9 to prevent infection remains limited at present.
Vitamin K is known to play a role in the regulation of blood coagulation and calcification of bone and vessel tissue. In addition, vitamin K could be involved in the regulation of innate immunity, with a stimulation of apoptotic cell clearance by phagocytes, and of inflammatory responses . Hence, it has been suggested that vitamin K could provide some benefits against COVID-19 complications [17, 39]. Our data suggest that it could also help prevent the infection by SARS-CoV-2.
The potential effect of dietary fibers on the risk of SARS-CoV-2 infection is likely resulting from their interaction with the gut microbiota, producing short-chain fatty acids (SCFA) and promoting a diverse and balanced community. The importance of the gut microbiota for efficient and balanced immune and inflammatory responses is well-established. In particular, SCFA contribute to the innate immune response through enhanced production of reactive oxygen species and phagocytosis, apoptosis, and modulation of neutrophil recruitment . Studies in animals have shown the importance of gut microbiota and dietary fiber intakes in the response against viral infection [41, 42]. Hence, although direct evidence in humans is scarce, our results are in line with the mechanistic evidence linking dietary fibers, the gut microbiota, and the immune function.
Consistent with our results observed for vitamins C, B9, K, and dietary fiber, we also observed a decreased susceptibility of SARS-CoV-2 infection with higher intakes of fruit and vegetables. Fruit and vegetables indeed provide a mix of these highly relevant compounds for the immune function (as discussed above), and also other bioactive compounds such as polyphenols . Our findings regarding the consumption of vegetables are consistent with those of the recently published prospective study in the UK-Biobank . A retrospective study in pregnant women also suggested a moderate effect of fruit and vegetable intake in the prevention of URTI . In contrast, a study observed that countries with higher consumptions of fruit had higher infection and mortality rates by COVID-19 but it was based on an ecological design, which did not allow the adjustment for individual factors that may cofound the studied associations . The fact that we observed associations with several compounds provided by fruit and vegetables makes it difficult to disentangle the specific effect of each compound, which will need to be explored in experimental studies and randomized trials.
Whereas most of the associations we observed were in line with mechanistic evidence and current hypotheses regarding the potential role of nutrition in the prevention of SARS-CoV-2 infection, we also observed an unexpected association between higher intakes of dairy products (especially milk) and calcium and a higher likelihood of SARS-CoV-2 infection. Indeed, dairy product intake is usually considered as beneficial for the immune system, anti-inflammatory processes, and the response to infections . These findings, along with those on fruits and vegetables, are somehow consistent with a Spanish prospective study , reporting that lower odds of COVID-19 infection are associated with a higher adherence to Mediterranean diet (i.e., a diet with high intakes of fruits and vegetables and limited intakes of dairy products). A possible mechanism that could partly explain this increased risk involves a calcium-sensitive interaction of SARS-CoV-2 with the ACE-2 receptor (its entry point in human cells). Hence, more available calcium could ease the entry of SARS-CoV-2 in the host cells . However, this result remains unclear and warrants further investigation.
Finally, other nutrients that were expected to have a potential beneficial effect against SARS-CoV-2 infection (e.g., selenium, zinc, copper, iron, vitamins A, D, and E) [6, 47] did not display associations with the risk of SARS-CoV-2 infection in our study. This could potentially relate to the nutritional status of our participants for these nutrients, with perhaps an appropriate status for immune function in most, and a relatively reduced range of intakes among participants. These nutrients could also be involved to mitigate the severity of symptoms or the prognosis once infected, which was beyond the scope of this study focusing on the susceptibility to infection. As regards vitamin D, meta-analyses have shown a potential benefit of a vitamin D supplementation for COVID-19 outcomes and mortality ; similarly, a meta-analysis showed a trend for a deleterious association between low serum 25(OH)D levels and COVID-19 related health outcomes . However, diet is not the major contributor to vitamin D intake, compared with sun exposure and the use of dietary supplements or medication. Specific investigation of vitamin D accounting for all its sources constitutes a perspective of this research work. Likewise, we did not observe associations with the indicators of overall diet quality. This tends to suggest a specific effect of some components playing a key role in immune function and the prevention of SARS-CoV-2 infection, which may be diluted when considering these overall indicators.
Main strengths of our study include the comprehensive assessment of SARS-CoV-2 seroprevalence with highly sensitive assays in a large sample, independent of whether or not the participant sought testing (contrary to studies using PCR results retrieved from medical records) or even had symptoms (that might not be specific to SARS-CoV-2 infections), and the detailed characterization of dietary intakes of participants prior to the pandemic (at least 6 and an average of 10.2 validated 24 h dietary records) allowing us to relate habitual diet to SARS-CoV-2 infection with a prospective design. The presence of antibodies indicates that a person has been infected with SARS-CoV-2, but does not indicate the exact date of the infection. Therefore, to guarantee as much as possible a prospective design, dietary data were considered until February 2020, the start of the epidemic in France. Yet, some limitations should be acknowledged. First, studies have suggested that the ELISA test has imperfect sensitivity (85–90%) [50, 51] and that anti-SARS-CoV-2 antibodies may decrease over time, which may have resulted in misclassification in a way that a person who has been infected with the virus might have not been positive according to the ELISA test; however, the date of collection of dried-blood spot kits was between May and October 2020 (i.e. not a very long time-frame since the beginning of the pandemic in France). Furthermore, the extent to which participants have actually been exposed to the virus is difficult to assess; hence, our results might be confused by behavioral factors, such as an increase awareness and application of protective measures in people who are more health-conscious and have a more balanced diet. To mitigate this potential bias, our models included numerous covariates related to the risk of being exposed to the virus (e.g., employment status during the lockdown, presence of children at home, index reflecting the application of protective measures). In addition, some data were not available in our study. In France, the collection of racial and ethnic data is generally not permitted in the framework of cohort studies, thus, these data were not available. Moreover, quantitative data about the use of dietary supplements (relevant when investigating specific nutrients such as vitamin D) was not yet available and thus, has not been included in this study. Details about subtypes of vitamin K (K1 and K2) were not available; even though these 2 subtypes might have similar biological functions, differences pertain to bioavailability and tissue distribution . However, because dietary sources of vitamin K1 and K2 are distinct (plant or animal sources, respectively), we used these as proxy. Next, the seronegative and seropositive groups differed at baseline according to several characteristics that constitute potential confounders susceptible to influence the studied associations in both directions. For instance, older age and higher physical activity levels were associated with healthier diets and lower risk of infection (which would tend to strengthen the observed associations), but the higher educational level was associated with healthier diets and higher risk of infection (which would tend to attenuate the observed associations). However, even though residual confounding (linked to unmeasured factors or inaccuracies in data assessment) cannot be totally ruled out, we largely accounted for potential confounding by adjusting all models for a wide panel of covariates (e.g., age, sex, educational, professional and socio-economical levels, smoking status, behaviors during the pandemic…) and by matching for age, sex and residential area in sensitivity analyses. Finally, as a long-term study on nutrition and health, NutriNet-Santé includes more women and individuals with overall higher socioeconomic status and healthier lifestyle and dietary habits compared to the general French population. This may limit the generalizability of our findings and might also have resulted in a smaller range in dietary intakes, thus a loss of statistical power.
In this study, conducted in a large population-based sample with seroprevalence data, fruit and vegetable intakes, and, consistently, dietary intakes of vitamin C, folates, vitamin K and fiber were associated with a lower susceptibility to SARS-CoV-2 infection. Further studies are needed in order to better understand the role played by dietary habits on the risk of SARS-CoV-2 infection. Insights from different approaches should help build robust scientific evidence. This includes well-designed randomized controlled trials (for factors with protective hypotheses), other observational prospective studies with detailed information about dietary exposures (including blood markers of micronutrient status) and outcome (including information on early symptoms and severity) to capture real-life behaviors in different countries and settings, and mechanistic approaches, using metabolomics, for instance, to understand the underlying pathways. Beyond its established role in the prevention of non-communicable chronic diseases , nutrition could therefore provide one strategic leverage to improve the immune function at the population level and contribute to the protection against SARS-CoV-2 infection.
Availability of data and materials
Researchers from public institutions can submit a collaboration request including their institution and a brief description of the project to collaboration@etude-nutrinet-sante. All requests will be reviewed by the steering committee of the NutriNet-Santé study. A financial contribution may be requested. If the collaboration is accepted, a data access agreement will be necessary and appropriate authorizations from the competent administrative authorities may be needed. In accordance with existing regulations, no personal data will be accessible.
Coronavirus disease 2019
Alternative Healthy Eating Index
Body mass index
Enzyme-linked immunosorbent assay
International Physical Activity Questionnaire
Programme National Nutrition Santé-guidelines score 2
Real-time polymerase chain reaction tests
Severe acute respiratory syndrome coronavirus 2
Upper respiratory tract infections
WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 25 Sept 2021.
Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021;79:289–300.
Chaari A, Bendriss G, Zakaria D, McVeigh C. Importance of dietary changes during the coronavirus pandemic: how to upgrade your immune response. Front Public Health. 2020;8:476.
Perez-Araluce R, Martinez-Gonzalez MA, Fernández-Lázaro CI, Bes-Rastrollo M, Gea A, Carlos S. Mediterranean diet and the risk of COVID-19 in the “Seguimiento Universidad de Navarra” cohort. Clin Nutr. 2021:S0261-5614(21)00190-4. [Online ahead of print]
Vu T-HT, Rydland KJ, Achenbach CJ, Van Horn L, Cornelis MC. Dietary behaviors and incident COVID-19 in the UK Biobank. Nutrients. 2021;13:2114.
Pecora F, Persico F, Argentiero A, Neglia C, Esposito S. The role of micronutrients in support of the immune response against viral infections. Nutrients. 2020;12:3198.
Hemilä H, Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD005532.pub3.
Johnston C, Barkyoumb G, Schumacher S. Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C Status: a randomized controlled trial. Nutrients. 2014;6:2572–83.
Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD000980.pub4.
Garaiova I, Muchová J, Nagyová Z, Wang D, Li JV, Országhová Z, et al. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study. Eur J Clin Nutr. 2015;69:373–9.
Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, et al. Could vitamins help in the fight against COVID-19? Nutrients. 2020;12:2550.
Raposo SE, Fondell E, Ström P, Bälter O, Bonn SE, Nyrén O, et al. Intake of vitamin C, vitamin E, selenium, zinc and polyunsaturated fatty acids and upper respiratory tract infection—a prospective cohort study. Eur J Clin Nutr. 2017;71:450–7.
Li L, Werler MM. Fruit and vegetable intake and risk of upper respiratory tract infection in pregnant women. Public Health Nutr. 2010;13:276–82.
Kamyari N, Soltanian AR, Mahjub H, Moghimbeigi A. Diet, nutrition, obesity, and their implications for COVID-19 mortality: development of a marginalized two-part model for semicontinuous data. JMIR Public Health Surveill. 2021;7:e22717.
Moghaddam A, Heller RA, Sun Q, Seelig J, Cherkezov A, Seibert L, et al. Selenium deficiency is associated with mortality risk from COVID-19. Nutrients. 2020;12:2098.
Gao D, Xu M, Wang G, Lv J, Ma X, Guo Y, et al. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging. 2021. https://doi.org/10.18632/aging.202557.
Dofferhoff ASM, Piscaer I, Schurgers LJ, Visser MPJ, van den Ouweland JMW, de Jong PA, et al. Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019. Clin Infect Dis. 2020:ciaa1258. [Online ahead of print].
Acosta-Elias J, Espinosa-Tanguma R. The folate concentration and/or folic acid metabolites in plasma as factor for COVID-19 infection. Front Pharmacol. 2020;11:1062.
Elham AS, Azam K, Azam J, Mostafa L, Nasrin B, Marzieh N. Serum vitamin D, calcium, and zinc levels in patients with COVID-19. Clin Nutr ESPEN. 2021;43:276–82.
Childs CE, Calder PC, Miles EA. Diet and immune function. Nutrients. 2019;11:1933.
Hercberg S, Castetbon K, Czernichow S, Malon A, Mejean C, Kesse E, et al. The Nutrinet-Santé Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status. BMC Public Health. 2010;10. https://doi.org/10.1186/1471-2458-10-242.
Touvier M, Kesse-Guyot E, Mejean C, Pollet C, Malon A, Castetbon K, et al. Comparison between an interactive web-based self-administered 24 h dietary record and an interview by a dietitian for large-scale epidemiological studies. BrJNutr. 2011;105:1055–64.
Lassale C, Castetbon K, Laporte F, Deschamps V, Vernay M, Camilleri GM, et al. Correlations between fruit, vegetables, fish, vitamins, and fatty acids estimated by web-based nonconsecutive dietary records and respective biomarkers of nutritional status. J Acad Nutr Diet. 2016;116:427–38.
Lassale C, Castetbon K, Laporte F, Camilleri GM, Deschamps V, Vernay M, et al. Validation of a web-based, self-administered, non-consecutive-day dietary record tool against urinary biomarkers. Br J Nutr. 2015;113:953–62.
Black AE. Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Relat Metab Disord. 2000;24:1119–30.
for the SAPRIS study group, Carrat F, Touvier M, Severi G, Meyer L, Jusot F, et al. Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study. BMC Infect Dis. 2021;21:169.
Carrat F, de Lamballerie X, Rahib D, Blanche H, Lapidus N, Artaud F, et al. Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. preprint. Infect Dis. 2020. https://doi.org/10.1101/2020.09.16.20195693.
Srour B, Fezeu LK, Kesse-Guyot E, Allès B, Debras C, Druesne-Pecollo N, et al. Ultraprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Santé Prospective Cohort. JAMA Intern Med. 2020;180:283.
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142:1009–18.
Varraso R, Chiuve SE, Fung TT, Barr RG, Hu FB, Willett WC, et al. Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study. BMJ. 2015;350 feb03 7:h286.
Chaltiel D, Adjibade M, Deschamps V, Touvier M, Hercberg S, Julia C, et al. Programme National Nutrition Santé – guidelines score 2 (PNNS-GS2): development and validation of a diet quality score reflecting the 2017 French dietary guidelines. Br J Nutr. 2019;122:331–42.
Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57.
Monteiro CA, Cannon G, Levy RB, Moubarac J-C, Louzada ML, Rauber F, et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr. 2019;22:936–41.
Carr A, Maggini S. Vitamin C and immune function. Nutrients. 2017;9:1211.
Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: the inflammation link and the role of nutrition in potential mitigation. Nutrients. 2020;12:1466.
Arvinte C, Singh M, Marik PE. Serum levels of vitamin C and vitamin D in a cohort of critically ill COVID-19 patients of a North American community hospital intensive care unit in May 2020: a pilot study. Med Drug Discov. 2020;8:100064.
Vahid F, Rahmani D. Can an anti-inflammatory diet be effective in preventing or treating viral respiratory diseases? A systematic narrative review. Clin Nutr ESPEN. 2021;43:9–15.
Suleiman L, Négrier C, Boukerche H. Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol. 2013;88:637–54.
Anastasi E, Ialongo C, Labriola R, Ferraguti G, Lucarelli M, Angeloni A. Vitamin K deficiency and covid-19. Scand J Clin Lab Invest. 2020;80:525–7.
Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. 2011;12:5–9.
Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12:1562.
He L-H, Ren L-F, Li J-F, Wu Y-N, Li X, Zhang L. Intestinal flora as a potential strategy to fight SARS-CoV-2 infection. Front Microbiol. 2020;11:1388.
Wallace TC, Bailey RL, Blumberg JB, Burton-Freeman B, Chen CO, Crowe-White KM, et al. Fruits, vegetables, and health: a comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake. Crit Rev Food Sci Nutr. 2020;60:2174–211.
Abdulah DM, Hassan AB. Relation of dietary factors with infection and mortality rates of COVID-19 across the world. J Nutr Health Aging. 2020;24:1011–8.
Perdijk O, van Splunter M, Savelkoul HFJ, Brugman S, van Neerven RJJ. Cow’s milk and immune function in the respiratory tract: potential mechanisms. Front Immunol. 2018;9:143.
Cashman DP. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease. Med Hypotheses. 2020;144:110027.
Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system–working in harmony to reduce the risk of infection. Nutrients. 2020;12:236.
Hariyanto TI, Intan D, Hananto JE, Harapan H, Kurniawan A. Vitamin D supplementation and Covid-19 outcomes: a systematic review, meta-analysis and meta-regression. Rev Med Virol. [Epub ahead of print]. https://doi.org/10.1002/rmv.2269.
Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj FG. The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism. 2021;119:154753.
Patel EU, Bloch EM, Clarke W, Hsieh Y-H, Boon D, Eby Y, et al. Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. J Clin Microbiol. 2021;59:e02257.
Rikhtegaran Tehrani Z, Saadat S, Saleh E, Ouyang X, Constantine N, DeVico AL, et al. Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PLoS One. 2020;15:e0237828.
Janssen R, Visser MPJ, Dofferhoff ASM, Vermeer C, Janssens W, Walk J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019. Br J Nutr. 2021;126:191–8.
Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–49.
The authors warmly thank all the volunteers of the NutriNet-Santé cohort for their continuous participation in the study and for participating in the SAPRIS-SERO project. The authors also thank Cédric Agaesse (manager), Alexandre De-Sa and Rebecca Lutchia (dietitians); Thi Hong Van Duong, Régis Gatibelza, Jagatjit Mohinder and Aladi Timera (computer scientists); Nicolas Dechamp (data-manager/statisticians); Sandrine Kamdem (health event validator); and Maria Gomes (participants’ support) for their technical contribution to the NutriNet-Santé study, for their dedication and engagement to collect and manage the data used for this study, and for ensuring continuing communication with the cohort participants. We thank the CEPH-Biobank staff for their adaptability and the quality of their work. In the virology department, we thank Dr Nadège Brisbarre and the technical staff for impeccable management of samples and serological assays.
The SAPRIS-SERO study group: Fabrice Carrat (Principal investigator), Pierre-Yves Ancel, Nathalie Bajos, Marie-Aline Charles, Gianluca Severi, Mathilde Touvier, Marie Zins (Co-principal investigators); Sofiane Kab, Adeline Renuy, Stephane Le-Got, Celine Ribet, Emmanuel Wiernik, Marcel Goldberg, Marie Zins (Constances cohort); Fanny Artaud, Pascale Gerbouin-Rérolle, Mélody Enguix, Camille Laplanche, Roselyn Gomes-Rima, Lyan Hoang, Emmanuelle Correia, Alpha Amadou Barry, Nadège Senina, Gianluca Severi (E3N-E4N cohort); Fabien Szabo de Edelenyi, Julien Allègre, Nathalie Druesne-Pecollo, Younes Esseddik, Serge Hercberg, Mathilde Touvier (NutriNet-Santé cohort); Marie-Aline Charles, Pierre-Yves Ancel, Valérie Benhammou, Anass Ritmi, Laetitia Marchand, Cecile Zaros, Elodie Lordmi, Adriana Candea, Sophie de Visme, Thierry Simeon, Xavier Thierry, Bertrand Geay, Marie-Noelle Dufourg, Karen Milcent (Epipage2 and Elfe child cohorts); Clovis Lusivika-Nzinga, Gregory Pannetier, Nathanael Lapidus, Isabelle Goderel, Céline Dorival, Jérôme Nicol, Fabrice Carrat (IPLESP – methodology and coordinating data center); Cindy Lai, Hélène Esperou, Sandrine Couffin-Cadiergues (Inserm); Jean-Marie Gagliolo (Institut de Santé Publique); Hélène Blanché, Jean-Marc Sébaoun, Jean-Christophe Beaudoin, Laetitia Gressin, Valérie Morel, Ouissam Ouili, Jean-François Deleuze (CEPH-Biobank); Stéphane Priet, Paola Mariela Saba Villarroel, Toscane Fourié, Souand Mohamed Ali, Abdenour Amroun, Morgan Seston, Nazli Ayhan, Boris Pastorino, Xavier de Lamballerie (Unité des Virus Emergents).
The SAPRIS/SAPRIS-SERO projects received funding from ANR (Agence Nationale de la Recherche, #ANR-20-COVI-000, #ANR-10-COHO-06), Fondation pour la Recherche Médicale (#20RR052-00), and Inserm (Institut National de la Santé et de la Recherche Médicale, #C20-26). The NutriNet-Santé cohort study was supported by the following public institutions: Ministère de la Santé, Santé Publique France, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Conservatoire National des Arts et Métiers (CNAM) and Université Sorbonne Paris Nord. Study investigators are independent from the funders. Funders had no role in the study design, the collection, analysis, and interpretation of data, the writing of the manuscript, or the decision to submit the article for publication.
Ethics approval and consent to participate
The NutriNet-Santé study is conducted in accordance with the Declaration of Helsinki, and all procedures were approved by the Institutional Review Board of the French Institute for Health and Medical Research (IRB INSERM #0000388FWA00005831) and by the National Commission on Informatics and Liberty (CNIL #908,450 and #909,216). All participants provided informed consent and an electronic signature. The study is registered at ClinicalTrials.gov (#NCT03335644). The SAPRIS protocol was approved by the Inserm ethics committee (approval #20-672 dated March 30, 2020). The SAPRIS-SERO study was approved by the Sud-Mediterranée III ethics committee (approval #20.04.22.74247) and electronic informed consent was obtained from all participants for dried-blood spot testing.
Consent for publication
Prof Fabrice Carrat reports personal fees from Imaxio and Sanofi, outside the submitted work. All other authors declare no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Computation of the simplified Programme National Nutrition Santé-guidelines score 2 (sPNNS-GS2) and of the Alternative Healthy Eating Index (AHEI)-2010. Supplementary Figure S1. Participants flowchart, NutriNet-Santé cohort (2009-2020) – SAPRIS-SERO. Supplementary Table S1. Nutritional intakes, food group consumption and SARS-CoV-2 infection (ELISA-S), sensitivity analyses, NutriNet-Santé cohort (2009-2020) – SAPRIS-SERO. Supplementary Figure S2. Food group contributions to the intakes of nutrients, NutriNet-Santé cohort (2009-2020) – SAPRIS-SERO. Supplementary Figure S3. Nutritional intakes and SARS-CoV-2 infection (ELISA-S) with a nested case-control design, NutriNet-Santé cohort (2009-2020) – SAPRIS-SERO. Supplementary Figure S4. Food group consumption and SARS-CoV-2 infection (ELISA-S) with a nested case-control design, NutriNet-Santé cohort (2009-2020) – SAPRIS-SERO.
About this article
Cite this article
Deschasaux-Tanguy, M., Srour, B., Bourhis, L. et al. Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort. BMC Med 19, 290 (2021). https://doi.org/10.1186/s12916-021-02168-1
- Cohort study